We are live on ! Find out more
ECM

ExodusPoint Capital Management Portfolio holdings

AUM $12.6B
1-Year Est. Return 30.13%
This Fund
S&P 500
This Quarter Est. Return
+27.17%
1 Year Est. Return
+30.13%
3 Year Est. Return
+85.63%
5 Year Est. Return
+104.04%
10 Year Est. Return
AUM
$3.85B
AUM Growth
+$2.03B
Cap. Flow
+$1.66B
Cap. Flow %
43.05%
Top 10 Hldgs %
17.46%
Holding
2,172
New
1,142
Increased
418
Reduced
161
Closed
448

Sector Composition

Rank Sector Weight
1 Technology 15%
2 Healthcare 9.88%
3 Industrials 9.44%
4 Financials 9.06%
5 Consumer Discretionary 7.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HMHC
1676
DELISTED
Houghton Mifflin Harcourt Company
HMHC
$59K ﹤0.01%
+32,379
New +$52K
AXIA
1677
AXIA Energia
AXIA
$58K ﹤0.01%
+13,007
New +$50.8K
CALA
1678
DELISTED
Calithera Biosciences, Inc
CALA
$57K ﹤0.01%
+535
New +$63.5K
HPR
1679
DELISTED
HighPoint Resources Corporation
HPR
$57K ﹤0.01%
+3,856
New +$55.9K
ALDX icon
1680
Aldeyra Therapeutics
ALDX
$93.5M
$55K ﹤0.01%
+13,085
New +$47.8K
LXRX icon
1681
Lexicon Pharmaceuticals
LXRX
$1.1B
$51K ﹤0.01%
+25,622
New +$50.2K
ARLO icon
1682
Arlo Technologies
ARLO
$1.65B
$50K ﹤0.01%
+19,245
New +$46.5K
NPKI
1683
NPK International
NPKI
$1.14B
$50K ﹤0.01%
+22,259
New +$37.7K
OSW icon
1684
OneSpaWorld
OSW
$2.66B
$49K ﹤0.01%
10,299
-3,201
-24% -$17.4K
IMGN
1685
DELISTED
Immunogen Inc
IMGN
$48K ﹤0.01%
10,367
-33,271
-76% -$142K
CPRX
1686
DELISTED
Catalyst Pharmaceutical
CPRX
$47K ﹤0.01%
+10,235
New +$46K
LJPC
1687
DELISTED
La Jolla Pharmaceutical Company
LJPC
$47K ﹤0.01%
+10,940
New +$66.6K
TRUE
1688
DELISTED
TrueCar
TRUE
$46K ﹤0.01%
+17,750
New +$45.6K
BSMX
1689
DELISTED
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
$44K ﹤0.01%
+12,100
New +$37.8K
RIGL icon
1690
Rigel Pharmaceuticals
RIGL
$750M
$42K ﹤0.01%
+2,310
New +$41.6K
CMRX
1691
DELISTED
Chimerix, Inc.
CMRX
$42K ﹤0.01%
+13,553
New +$35.1K
QUAD icon
1692
Quad
QUAD
$525M
$38K ﹤0.01%
+11,808
New +$36.2K
VSTM icon
1693
Verastem
VSTM
$610M
$38K ﹤0.01%
1,838
-4,470
-71% -$118K
PDLI
1694
DELISTED
PDL BioPharma, Inc.
PDLI
$36K ﹤0.01%
+12,434
New +$39.3K
LRFC
1695
DELISTED
Logan Ridge Finance Corp
LRFC
$35K ﹤0.01%
2,237
+32
+1% +$578
MITT
1696
TPG Mortgage Investment Trust
MITT
$225M
$33K ﹤0.01%
3,473
+57
+2% +$545
CHS
1697
DELISTED
Chicos FAS, Inc.
CHS
$32K ﹤0.01%
23,054
+5,094
+28% +$6.92K
ABUS icon
1698
Arbutus Biopharma
ABUS
$915M
$31K ﹤0.01%
17,000
+3,131
+23% +$5.12K
NWG icon
1699
NatWest
NWG
$76.4B
$30K ﹤0.01%
9,286
-19,943
-68% -$62K
ANH
1700
DELISTED
Anworth Mortgage Asset Corporation
ANH
$29K ﹤0.01%
+17,129
New +$26.6K

Similar funds

ExodusPoint Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, ExodusPoint Capital Management held 2,172 positions worth $3.85B, up 111% from $1.82B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

ExodusPoint Capital Management deployed $1.66B of net new capital in Q2 2020, opening 1,142 new positions and adding to 418 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 266,338 shares worth $82.1M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 12% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Amazon, an estimated $27.8M trimmed.

  • ExodusPoint Capital Management's largest Q2 2020 buy was State Street SPDR S&P 500 ETF Trust: 266,338 shares worth $82.1M.
  • ExodusPoint Capital Management added most to PG&E in Q2 2020, an estimated $38.2M increase.
  • ExodusPoint Capital Management's biggest Q2 2020 reduction was Amazon, cutting an estimated $27.8M.
  • ExodusPoint Capital Management fully exited McKesson in Q2 2020, selling an estimated $18.1M.
  • ExodusPoint Capital Management's ten largest holdings make up 17% of its $3.85B portfolio in Q2 2020.
  • ExodusPoint Capital Management opened 1,142 new positions and closed 448 in Q2 2020.
  • ExodusPoint Capital Management's portfolio value rose 111% quarter-over-quarter to $3.85B.

Based on ExodusPoint Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.